| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| April 28, 2026 | ±1.8% | +0.2% | over-priced |
| October 30, 2025 | ±2.4% | +3.0% | under-priced |
| August 1, 2025 | ±1.6% | +4.8% | under-priced |
| April 22, 2025 | ±2.5% | -1.5% | over-priced |
| October 22, 2024 | ±1.7% | -4.5% | under-priced |
| July 23, 2024 | ±1.5% | -5.7% | under-priced |
| April 23, 2024 | ±1.4% | +5.5% | under-priced |
| October 24, 2023 | ±1.3% | -1.1% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $2.00 | $4.2B | $675M |
| Q4 FY2025 | $1.50 | $4.1B | $510M |
| Q3 FY2025 | $1.34 | $4.2B | $454M |
| Q2 FY2025 | $1.53 | $4.2B | $512M |
Kimberly-Clark Corp. (KMB) reports in 92 days, with the next report estimated for September 13, 2026. Across the last 8 reports, options priced an average ±1.8% earnings move while the stock actually moved 3.3% on average — the market has been roughly fair on KMB's earnings risk. Fundamentals into the print: EPS up 17.6% year-over-year, revenue up 2.7%. QuantLogix's live 5-factor engine currently reads KMB as a buy at 61/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →